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To our knowledge, this study
is the first to quantify intra-
fraction motion of esopha-
geal tumors on cine-
magnetic resonance imaging
(MRI). We successfully
measured tumor movement
in a large group of patients
(nZ36), using a fast nonin-
vasive semiautomatic
method to quantify motion in
3 directions. Tumor mobility
was highly variable between
patients. Cine-MRI is a use-
ful modality to analyze indi-
vidual motion patterns.
These patterns are useful for
the development of individ-
ual treatment strategies.Reprint requests to: Gert J. Meijer, PhD,
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http://dx.doi.org/10.1016/j.ijrobp.2013.10.036Purpose: To quantify the movement of esophageal tumors noninvasively on cine-magnetic
resonance imaging (MRI) by use of a semiautomatic method to visualize tumor movement
directly throughout multiple breathing cycles.
Methods and Materials: Thirty-six patients with esophageal tumors underwent MRI. Tumors
were located in the upper (8), middle (7), and lower (21) esophagus. Cine-MR images were
collected in the coronal and sagittal plane during 60 seconds at a rate of 2 Hz. An adaptive cor-
relation filter was used to automatically track a previously marked reference point. Tumor move-
ment was measured in the craniocaudal (CC), lefteright (LR), and anteroposterior (AP)
directions and its relationship along the longitudinal axis of the esophagus was investigated.
Results: Tumor registration within the individual images was typically done at a millisecond
time scale. The mean (SD) peak-to-peak displacements in the CC, AP, and LR directions were
13.3 (5.2) mm, 4.9 (2.5) mm, and 2.7 (1.2) mm, respectively. The bandwidth to cover 95% of
excursions from the mean position (c95) was also calculated to exclude outliers caused by spo-
radic movements. The mean (SD) c95 values were 10.1 (3.8) mm, 3.7 (1.9) mm, and 2.0 (0.9)
mm in the CC, AP, and LR dimensions. The end-exhale phase provided a stable position in the
respiratory cycle, compared with more variety in the end-inhale phase. Furthermore, lower
tumors showed more movement than did higher tumors in the CC and AP directions.
Conclusions: Intrafraction tumor movement was highly variable between patients. Tumor posi-
tion proved the most stable during the respiratory cycle in the end-exhale phase. A better under-
standing of tumor motion makes it possible to individualize radiation delivery strategies
accordingly. Cine-MRI is a successful noninvasive modality to analyze motion for this purpose
in the future.  2014 Elsevier Inc.Department of Radiation
, Heidelberglaan 100 (HP
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Radiation therapy is an integral part of the treatment of esophageal
tumors in all stages of the disease. Administered preoperatively
with concurrent chemotherapy, radiation therapy significantly
improves overall survival rates in potentially curable patients (1).
If surgery is not an option because of age, morbidity, or extent of
disease, definitive (chemo)radiation is the primary treatment (2).
A doseeresponse relationship has been established for
esophageal tumors (3, 4), suggesting that dose escalation could
lead to a higher complete pathologic response rate in patients
treated neoadjuvantly, and fewer local recurrences in the definitive
chemoradiation group. However, dose escalation to the primary
tumor is a delicate matter because the esophagus is both target and
organ at risk. To prevent a higher toxicity, cautious administration
of the boost dose is required without spilling of dose to the healthy
surroundings.
Given that esophageal tumors are subject to respiratory and
cardiac movement, margins are applied to ensure that sufficient
dose is delivered to the tumor. In the future, motion management
strategies may improve targeting the dose by reducing margins. As
such, a better understanding of tumor movement is essential to
explore the potential of safe dose escalation in combination with
motion management strategies.
Previous studies have quantified esophageal motion on
4-dimensional computed tomography (4D-CT) (5-9). However, the
use of 4D-CT for this purpose frequently includes the need for
fiducial markers because of poor contrast features, provides addi-
tional radiation exposure, and visualizes the tumor position indi-
rectly in time, owing to binning of data according to respiration
phase. MRI, with its superior soft-tissue contrast, is an effective
modality for noninvasive visualization of the tumor. Cine-MRI
acquires subsequent images with a high temporal resolution and
has already been of value in the quantification of intrafraction
motion in other tumors (10-12). This study is the first to use cine-
MRI for the quantification of esophageal tumor motion providing
data on a large group of patients. The aim was to quantify
3-dimensional movement of esophageal tumors noninvasively by
using a semiautomatic method to characterize tumor movement
directly throughout multiple breathing cycles. This motion char-
acterization may aid the development of motion management
strategies in preparation for future dose escalation strategies.
Methods and Materials
Patients
Thirty-six patients with pathologically verified tumors of the
esophagus were included in this study between May 2011 and
February 2013. Patients underwent MRI approximately 1 week
before the start of treatment.
Image acquisition and registration
The MR imaging was performed on a 1.5-T scanner (1.5T
Achieva, Philips, Best, The Netherlands) using a 16-channel
phased array coil for reception (Torso XL, Philips). Patients
were scanned in supine position with arms placed alongside the
body. Before cine-MR imaging, T2-weighted turbo spin-echo
images were obtained in the axial, coronal, and sagittal planes.These images were then used to plan the 2-dimensional (2D)
coronal and sagittal cine-MR scans. The slice (7 mm) was placed
through the longitudinal axis of the esophageal tumor. The cine-
MRI scans consisted of 2D balanced steady-state free precession
sequences to gain a sufficient signal-to-noise ratio. The following
scan parameters were used: flip angle 50, TE 1.44 ms, TRZ 2.9
ms, NSA 1, pixel size 2.01 mm  2.01 mm for the coronal images.
The parameters for the sagittal images were identical except for
the pixel size: 1.43 mm  1.43 mm. A series of images was
collected during 60 seconds of free breathing at a rate of 2 Hz.
Cine-MR scans were recorded with a bandwidth of 1935.6 Hz/
mm (sagittal) and 2662.6 Hz/mm (coronal). Considering amaximum
field inhomogeneity in the tumors of approximately 100 Hz, the
maximal geometric error remained <0.05 mm. Given that this is
considerably smaller than the voxel sizes used, the imaging distortion
was considered negligible for measurement of the tumor motion.
Quantification of tumor motion
To quantify movement, a reference point on the caudal tumor
border was marked by a single physician on the 10th frame of
each cine-MRI, skipping the prior frames because the contrast of
the steady-state of the cine-MR sequence had not yet been
established (Fig. 1). This point was automatically tracked in
subsequent frames by use of a minimum output sum of squared
error (MOSSE) adaptive correlation filter (13). The selected point
provided the center of a search window (64 pixels  64 pixels).
Correlating the filter over the search window in the next frame
tracked the point. The filter was determined by requiring that
correlation with the initial frame produced a compact Gaussian
peak centered on the tracking point. The location corresponding to
the maximum value in the correlation output indicated the new
position of the target. The caudal tumor border was chosen to
track because its sharper contrast with the surrounding tissues
made it suitable for tracking.
Tracking provided coordinates of the tumor reference point in
each frame, which were used to calculate tumor movement.
Tumor motion in the craniocaudal (CC) direction was determined
on both the coronal and sagittal scans. Lefteright (LR) and
anteroposterior (AP) movement were evaluated on coronal and
sagittal images, respectively. If images were acquired in an
angulated plane with respect to these 3 directions, vectors were
corrected to represent the actual CC, LR, and AP directions. In-
dividual patient data were evaluated and summarized by use of the
peak-to-peak amplitudes of motion in each direction. Furthermore,
the smallest range to cover 95% of excursions from the time-
average over all instances (c95) was also calculated. This c95
provided a more robust measure for tumor motion by excluding
outliers caused by sporadic movement (eg, swallowing, hiccups)
seen on the scans.
Craniocaudal motion and the respiratory cycle
The length and frequency of the cine-MRI acquisition made it
possible to measure tumor motion throughout multiple breathing
cycles. For each patient, the CC motion pattern was inspected and
analyzed (Fig. 2). The peaks and troughs of each motion pattern
were defined as inhale or exhale peaks (ie, the greatest deviation
from the mean [time-averaged] position at the end-inhale phase
and end-exhale phase). For each patient, the inhale and exhale
peaks were grouped and the mean and standard deviation (SD)
Fig. 1. (A) Coronal and (B) sagittal cine-magnetic resonance image of a lower esophageal tumor, with the reference point (white) for the
tracking filter shown on the caudal tumor border.
Fig. 2. Representative craniocaudal motion pattern in 1 patient
of a point tracked on the caudal tumor border. The variety in the
end-inhale phase (peaks) and the stability of the end-exhale phase
(troughs) are evident.
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phase.
Tumor location
To investigate the relationship between mobility and location
along the longitudinal axis of the esophagus, tumor location was
determined. Tumors were classified into 3 groups (upper, middle,
and lower tumors) according to the American Joint Committee on
Cancer staging guidelines (14).
Statistical methods
All analyses were executed with SPSS, version 20.0. Tumor move-
ment in the CC, LR, and AP directions was determined for each
patient. The peak-to-peak amplitude and c95 of each patientwas then
used to calculate themeanandstandard deviation in eachdirection for
the whole group. To analyze the stability of the end-inhale and end-
exhale phase of the respiratory cycle, a paired-samples t testwas done
on the standard deviations of inhale and exhale peaks per patient. To
assess differences in motion between upper, middle, and lower
tumors, an analysis of variance was performed. If a significant
difference was found between these 3 groups, pairwise comparisons
with a Bonferroni correction were performed to identify which group
contributed to this difference. For all statistical tests performed, a
value of P<.05 was considered statistically significant.
Results
Clinical characteristics of patients
Thirty-six patients were included in this study. The patient charac-
teristics are summarized in Table 1. In 1 patient only coronal cine-
MRI was performed, and in another patient only sagittal cine-MRI
was acquired. Six sagittal scans were excluded because of anerroneously set slice thickness (3 mm instead of 7 mm), causing
insufficient signal-to-noise ratio in the images. As a result, 35 coronal
and 29 sagittal cine-MRI scans were available for analysis.
Quantification of tumor motion
Tumor registration within the individual images was typically
done at a millisecond time scale. In 28 patients, both coronal and
sagittal cine-MRI scans were obtained, making it possible to
measure CC motion in both planes. CC motion on sagittal images
was 9% less than CC motion tracked on coronal images. To
prevent underestimation of movement, further analysis of CC
motion was done on the coronal images. Motion for each direction
is summarized in Table 2. The greatest motion was found in the
CC direction, with a mean (SD) peak-to-peak amplitude of 13.3
(5.2) mm, followed by the AP (4.9 [2.5] mm) and the LR (2.7 [1.2]
Table 1 Patient characteristics (nZ36)
Sex, n (%)
Male 24 (66.7)
Female 12 (33.3)
Age, y, mean (SD) 68 (10.5)
Tumor volume, mL, mean (SD) 68.5 (60.8)
Histology, n (%)
SCC 16 (44.4)
AC 20 (55.6)
Stage,*,y n (%)
IIA-B 9 (25.0)
IIIA-C 10 (27.8)
IV 6 (16.7)
Unknown 11 (30.6)
Tumor location,* n (%)
Upper 8 (22.2)
Middle 7 (19.4)
Lower 21 (58.3)
RT treatment, n (%)
Neoadjuvant 21 (58.3)
Primary 10 (27.8)
Palliative brachytherapy 5 (13.9)
Abbreviations: AC Z adenocarcinoma; RT Z radiation therapy;
SCC Z squamous cell carcinoma; SD Z standard deviation.
* Classified according to the American Joint Committee on Cancer
guidelines (14).
y 7 patients underwent magnetic resonance imaging after neo-
adjuvant treatment, for these patients stage was determined
“unknown”.
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high interpatient variability in tumor motion.
Craniocaudal motion and the respiratory cycle
Visual inspection of the cine-MR images showed a relationship
between tumor and diaphragmatic motion consistent with the close
correlation between the respiratory cycle andCCmotion described in
the literature (8, 15). Analysis of inhale and exhale peaks per patient
showed a statistically significant difference with overall mean (SD)
values of 4.4 (2.1) mm and 3.2 (0.7) mm, respectively (P<.001). The
greater variation in standard deviation of the inhale peaks indicated
morevariation in tumorposition in the end-inhale phase (Fig. 3).Last,
the stability of exhale peaks in comparison with inhale peaks
remained in very mobile tumors (Fig. 3).Table 2 Summary of tumor motion in 3 directions
Direction
Peak-to-peak
amplitude (mm) c95* (mm)
Mean SD Range Mean SD Range
Craniocaudaly 13.3 5.2 2.7-24.5 10.1 3.8 2.4-17.3
Left-righty 2.7 1.2 0.9-6.1 2.0 0.9 0.5-5.1
Anteroposteriorz 4.9 2.5 1.6-11.3 3.7 1.9 1.2-7.5
Abbreviation: SD Z standard deviation.
* c95 represents the bandwidth covering 95% of tumor motion.
y nZ35 (coronal cine-MRI).
z nZ29 (sagittal cine-MRI).Association between tumor location and
esophageal mobility
Figure 4 shows the relationship between mobility and location of
the tumors for the 3 directions of motion studied. There were 8
tumors located in the upper, 7 in the middle, and 21 in the lower
part of the esophagus (14). The lower tumors had the greatest
movement, requiring a mean (SD) range of 11.5 (3.4) mm to cover
95% of movement from the mean position (c95) in the CC
direction. These ranges were 10.7 (3.6) mm in the middle group
and 6.1 (1.3) mm in the upper group. A significant difference
(PZ.001) was found in CC movement between the 3 groups. The
upper group differed significantly from the middle (PZ.023) and
lower (PZ.001) groups, but no difference was found in comparing
the middle and lower groups (PZ1.000) (Fig. 4A).
A trend was also seen in the APmovement, with a mean (SD) c95
in the lower, middle, and upper groups of 4.7 (1.7) mm, 3.2 (2.2)mm,
and 2.0 (0.4) mm. Differences between the 3 groups in AP motion
were significant aswell (PZ.003). Themovement of the upper group
tumors differed significantly from that of the lower tumors (PZ.003)
but not from the middle tumors (PZ.585) (Fig. 4C). Again, the
middle and lower tumors did not differ significantly (PZ.162).
No significant difference was seen between tumor location for
the LR direction (PZ.313) (Fig. 4B), with mean (SD) c95s of 2.3
(1.1) mm, 1.7 (0.37) mm, and 1.8 (0.49) mm in the lower, middle,
and upper groups, respectively.Discussion
The greatest esophageal tumormotionwas found in the CCdirection,
followed by the AP direction and minimal movement in the LR
direction. The end-exhale phase provided the most stable position
independently of the mobility of the tumor. Last, in our study an
associationwas identified between the position of the tumor along the
longitudinal axis of the esophagus and its mobility. Tumors in the
lower esophagus showedmoremovement in the CC andAPdirection
than did higher tumors. This greater movement of lower esophageal
tumorsmaybe explainedby anatomy (eg, proximity to the diaphragm
and influence of respiratory movement).
Several other studies have also identified tumors in the lower
esophagus as the most mobile tumors (5-7). Dieleman et al (5)
studied esophageal motion in 29 patients with nonesophageal
malignancies on normal breathing 4D-CT and described larger
margins needed to encompass all movement in the lower esoph-
agus. In the LR and AP directions, these margins were 5 mm for
the proximal esophagus, 7 mm and 6 mm in the midesophagus,
and 9 mm and 8 mm in the distal esophagus. Motion in the CC
direction was not analyzed in their study. Similarly, Patel et al (6)
found distal tumors to have significantly greater CC and AP
motion than proximal or midesophageal tumors. In that study, 30
patients underwent 4D-CT scans, and movement in 3 directions
was analyzed. An association between tumor location and
magnitude of motion in the CC and AP directions was found, but
not for the LR movement. A study by Yaremko et al (7) also
showed a consistent increase in average gross tumor volume
displacement with descent along the esophageal axis. This was
done by determining the motion for 31 tumors in the distal
esophagus on respiratory-gated 4D-CT images by mapping the
gross tumor volume on the CT images at maximal inspiration and
maximal expiration.
Fig. 3. Range covering 95% of tumor motion (c95) in the cranio
caudal direction and the standard deviation (SD) of the exhale and
inhale peaks, illustrating the stability of the end-exhale position
independently of the degree of motion compared with a greater
variety in the end-inhale position.
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movement using4D-CTimages,where the respiratory cycle is binned
into inhale and exhale phases and the precise position of the tumor at
the end of these phases cannot be determined. In fact, the fourth
dimension of these images does not represent the time directly.
Therefore, irregularities in the breathing pattern cannot be captured
with 4D-CT.An exception is research byYamashita et al (8), inwhich
volumetric 4D-CT scanning was used to acquire a full 3D image
every 0.5 seconds during 20 seconds. Their study analyzed the 3DFig. 4. Scatter plots showing the mean c95 for upper, middle, and
anteroposterior directions. Data were analyzed using 1-way analysis of v
the bandwidth covering 95% of tumor motion. Asterisks over the respec
***PZ.003).movement of 22 markers placed near esophageal malignancies in 12
patients. Similarly to other studies, Yamashita et al (8) analyzed CC
motion separately for upper, middle, and lower tumors and deter-
mined an increase in esophageal mobility for lower tumors. They
concluded that margins of 4.3 mm, 7.4 mm, and 13.8 mm were
required to cover 95% of the tumor motion in the CC direction for
upper,middle, and lower tumors, respectively. These findingswere in
line with our results (10.1 mm for the entire group).
To our knowledge, this is the first study in which cine-MRI has
been used to quantify esophageal tumor motion. It also represents
the largest group of esophageal tumors (nZ36) in which intra-
fraction motion is examined. Cine-MRI provides sufficient soft-
tissue contrast for the visualization of esophageal tumors without
the need for invasive fiducial markers. Also, there is no additional
radiation exposure for the patient. Use of the MOSSE filter to track
the motion on the cine-MR images allowed for fast semiautomatic
tracking of the tumor, eliminating the interobserver dependency of
contouring the tumor in each frame. Furthermore, it was possible to
observe motion patterns directly during 60 seconds, depicting
multiple breathing cycles. This allowed the identification of the
end-exhale phase as the most stable phase. Radiation field margins
typically applied to esophageal tumors are approximately 5 cm in
the CC direction and 2 cm radially (16). The clinical target
volumedplanning target volume expansion included in these
margins is usually 1 to 2 cm. On the basis of our findings, this is
sufficient to account for motion in all directions. However, a smaller
margin is potentially sufficient in the axial direction to account for
LR and AP motion. Our results also suggest that margins could be
reduced by individualizing margins after motion measurement.
However, before smaller margins are introduced in clinical practice,
other uncertainties (eg, setup error) must be investigated.
There were also some limitations to this study. The MOSSE
filter works best when tracking a point with distinct contrast in
relation to its surroundings; thus, the tumor border was chosen.
Also, a difference in CC motion measured on sagittal compared
with coronal images was found. The MOSSE filter is susceptible
to static structures in proximity of the point being tracked. In the
sagittal scans the spinal vertebrae were often near the tumor. This
may explain why CC motion in the sagittal images was 9% lesslower tumors in the (A) craniocaudal, (B) lefteright, and (C)
ariance with Bonferroni’s multiple comparison tests. c95 represents
tive data pair indicate significant P values (*PZ.023, **PZ.001,
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such as out-of-plane motion or irregular breathing patterns on the
consecutively acquired scans may have also contributed to this
difference. Also, measurements on cine-MRI do not represent the
exact 3D displacement of the esophagus, but the 2D displacement
of the point tracked, making it susceptible to effects of out-of-
plane motion. However, to minimize the effect of out-of-plane
motion, our measurement plane was chosen to depict the greatest
length of the tumor, which was closely related to the CC direction.
Novel 4D-MRI techniques provide the possibility to resolve the
error of out-of-plane motion, offering a promising method for
future work (17). Previous work by Crijns et al (18) validated the
use of the MOSSE filter as a tracker of kidney motion on cine-
MRI. The average measurement errors found for image process-
ing were approximately half a voxel, making it insignificant in
comparison with the tumor motion found in our study.
To evaluate the clinical implications of our results, future work
should address the dosimetric consequences of esophageal movement
on radiation therapy treatment planning for esophageal tumors. Also,
with the method used in our study, cine-MRI could be used in the
pretreatmentworkflow for quickassessment of tumormotion.Another
application of cine-MRI could be to evaluate the effect of tumor mo-
tion on radiation delivery in a brachytherapy (boost) setting. A better
understanding of tumor motion makes it possible to individualize ra-
diation delivery strategies accordingly. Further research into assessing
benefits of such (individual) motion management strategies could be
of value. Moreover, in exploring intrafraction motion management
methods, such as gated radiation delivery, our findings on the relative
stable tumor position in the end-exhale phase could be used. Last, with
advances toward MRI-guided radiation delivery, our method could
become increasingly useful and attainable clinically (19).
Conclusion
A fast image tracking method was used successfully in this study to
quantify the motion of esophageal tumors on cine-MRI non-
invasively. Themotion of esophageal tumors was found to be highly
variable between patients. The greatest mobility was seen in the CC
direction, followed by theAP andLR directions. An associationwas
observed between CC and AP movement and the location of the
tumor along the axis of the esophagus, with greatest motion in the
lower esophageal tumors. Last, our study identified that the most
stable tumor position is during the end-exhale phase. This infor-
mation could be used in the development of strategies for gated
radiation delivery. In conclusion, a better understanding of esoph-
ageal tumor motion makes it possible to individualize radiation
delivery strategies accordingly. Cine-MRI is a successful noninva-
sive modality to analyze motion for this purpose in the future.
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